Radiosensitization by iodo-deoxyuridine in cultured SW-1573 human lung tumor cells

Area of Science:

• Radiation Oncology
• Cell Biology
• Cancer Research

Background:

• Halogenated pyrimidines are investigated for their potential to enhance cancer treatment efficacy.
• Iododeoxyuridine (IdUrd) is a halogenated pyrimidine analog used in radiosensitization studies.
• Understanding radiosensitization mechanisms is crucial for optimizing cancer therapy.

Purpose of the Study:

• To investigate the radiosensitizing effects of iododeoxyuridine (IdUrd) in human SW-1573 lung tumor cells.
• To determine how IdUrd influences cell survival following gamma irradiation.
• To analyze the impact of IdUrd on the parameters of radiation survival curves.

Main Methods:

• SW-1573 lung tumor cells were cultured with and without 4 μM IdUrd.
• Cells were exposed to single doses of gamma radiation (up to 8 Gy) from a Cesium-137 source.
• Cell survival was assessed using clonogenic assays, and data were analyzed using linear-quadratic models.

Main Results:

• Radiosensitization by IdUrd was observed in both exponentially growing and plateau-phase cells.
• Linear-quadratic analysis revealed that IdUrd primarily increased the alpha-value, suggesting enhanced fixation of potentially lethal damage (PLD).
• The beta-value, related to sublethal damage (SLD), remained unaffected by IdUrd treatment.

Conclusions:

• IdUrd effectively radiosensitizes human lung tumor cells.
• The radiosensitization mechanism involves an increase in the alpha-term, indicating improved PLD fixation.
• The clinical relevance lies in IdUrd's potent effect in the low-dose region of the cell survival curve (alpha D).